Similar to other vascular anomalies, even though the receptors are expressed by all Ecs, loss of function genetic variants in ALK1 or ENG (encountered in 90% of HHT patients) cause localized AVMs in the liver or lungs, respectively[13]. This evidence concerns the gene ENG and hereditary hemorrhagic telangiectasia.